| NT (mm) |
PAPP-A (MoM) |
freeβ-HCG (MoM) |
AFP (MoM) |
HCG (MoM) |
uE3 (MoM) |
diagnosed pathology |
pregnancy outcome |
| 1.7 |
0.23 |
0.51 |
1.72 |
1.33 |
0.13 |
trisomy 13* |
terminated |
| 6 |
1 |
2.4 |
|
|
|
trisomy 21 |
terminated |
| 4.4 |
0.22 |
4.04 |
|
|
|
trisomy 21 |
terminated |
| 0 |
0 |
0 |
0.53 |
2.44 |
0.18 |
trisomy 21 |
terminated |
| 2.2 |
0.07 |
0.09 |
0.34 |
0.02 |
0.27 |
triploidy |
terminated |
| 3.7 |
0.9 |
0.36 |
|
|
|
HLHS*** |
terminated |
| |
|
|
4.97 |
0.62 |
0.3 |
anencephaly |
terminated |
| |
|
|
12.01 |
1.87 |
0.23 |
anencephaly |
terminated |
| |
|
|
7.67 |
0.52 |
1.31 |
gastroschisis |
terminated |
| 1.4 |
0.24 |
0.14 |
|
|
|
fetal hydrops** |
terminated |
| |
|
|
4.19 |
1.1 |
1.44 |
bilateral renal agenesis |
terminated |
| |
|
|
5.12 |
0.78 |
1.36 |
neural tube defect |
terminated |
*risk for trisomy 21 and trisomy 18 was negative
**karyotype 46,XY
***HLHS - hypoplastic left heart syndrome, karyotype 46,XY |
